Risk of Major Adverse Cardiovascular Events Among Users of Naldemedine Compared With Other Medications Used for Opioid Induced Constipation in Adult Patients With Chronic Non-Cancer Pain in a Healthcare Claims Database
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2019
Price : $35 *
At a glance
- Drugs Naldemedine (Primary) ; Lubiprostone; Naloxegol
- Indications Constipation
- Focus Adverse reactions
- Sponsors Shionogi
- 02 Apr 2019 Status changed from not yet recruiting to recruiting.
- 29 Nov 2018 Planned initiation date changed from 31 Oct 2018 to 30 Jan 2019.
- 02 Nov 2018 New trial record